Event chart NUVASIVE, INC. |
|
|
Upcoming events on NUVASIVE, INC. |
|
06/03/22 | | International Society for the Advancement of Spine Surgery Conference |
07/28/22 | | Interim 2022 Earnings Release (Projected) |
11/02/22 | | Q3 2022 Earnings Release (Projected) |
02/22/23 | | FY 2022 Earnings Release (Projected) |
05/03/23 | | Q1 2023 Earnings Release (Projected) |
|
Past events on NUVASIVE, INC. |
|
05/11/22 | 10:00am | | Annual General Meeting |
05/04/22 | 04:30pm | | Q1 2022 Earnings Call |
05/04/22 | 04:05pm | | Q1 2022 Earnings Release |
03/08/22 | 11:10am | | Cowen & Co. Health Care Conference |
02/23/22 | 04:30pm | | FY 2021 Earnings Call |
02/23/22 | 04:10pm | | FY 2021 Earnings Release |
01/12/22 | 03:00pm | | JP Morgan Healthcare Conference |
12/04/21 | | Cervical Spine Research Society Meeting |
11/23/21 | 12:00pm | | Piper Sandler Virtual Healthcare Conference |
11/11/21 | 11:20am | | Credit Suisse Healthcare Conference |
|
Past dividends on NUVASIVE, INC. |
|
- No events available -
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 1 030 1 030 -0,08% | 1 102 1 104 -0,25% | 1 168 1 163 0,45% | 1 051 1 057 -0,59% | 1 139 1 136 0,27% | 1 222 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 265 275 -3,4% | 267 279 -4,2% | 299 294 1,7% | 219 224 -2,2% | 256 263 -2,9% | 308 |
Operating profit (EBIT) M $ |
Released Forecast Spread | 145 171 -15% | 138 169 -18% | 185 184 0,72% | 117 116 0,63% | 145 145 0,58% | 166 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 74,2 80,7 -8,0% | 8,72 18,3 -52% | 80,5 71,3 13% | -47,5 -36,9 -29% | -58,4 -9,46 -517% | 96,6 |
Net income M $ |
Released Forecast Spread | 83,0 77,6 6,9% | 12,5 18,8 -34% | 65,2 52,6 24% | -37,2 -30,1 -23% | -64,1 -15,5 -313% | 79,1 |
EPS $ |
Released Forecast Spread | 1,50 1,47 1,9% | 0,24 0,33 -27% | 1,23 1,01 22% | -0,72 -0,58 -25% | -1,24 -0,38 -225% | 1,37 | Announcement Date | 02/26/2018 | 02/20/2019 | 02/20/2020 | 02/25/2021 | 02/23/2022 | - |
|
|
Fiscal Period : December | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales M |
Released Forecast Spread | 601 189
| 260 262 -0,77% | 204 204 -0,03% | 295 258 15% | 292 298 -2,1% | 271 261 4,1% | 295 286 3,3% | 271 290 -6,5% | 302 299 1,1% | 291 277 4,8% | 307 | 301 | 323 | 307 | 325 |
Operating income (EBITDA) M $ |
Released Forecast Spread |
| 57,3 59,6 -3,9% | 8,29 7,21 15% | 75,4 48,1 57% | 78,0 71,9 8,5% | 63,4 57,8 9,7% | 71,4 66,4 7,4% | 55,6 71,6 -22% | 65,2 68,2 -4,3% | 71,5 62,8 14% | 77,2 | 77,0 | 84,6 | 73,2 | 85,2 |
Operating profit (EBIT) M $ |
Released Forecast Spread |
| 43,9 34,6 27% | -19,9 -19,5 -1,8% | 46,5 22,5 106% | 46,1 45,2 2,0% | 35,3 30,6 15% | 40,9 35,5 15% | 30,4 39,6 -23% | 38,8 38,0 2,3% | 34,0 30,6 11% | 41,7 | 40,9 | 48,3 | 41,8 | 49,5 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread |
| 10,1 6,71 51% | -65,2 -53,7 -21% | 6,45 -10,4 162% | 1,06 8,34 -87% | -8,13 2,53 -421% | 7,64 9,39 -19% | -24,0 12,3 -294% | -33,9 9,75 -448% | 23,8 8,46 182% | 22,5 | 21,6 | 26,6 | 15,8 | 26,2 |
Net income M $ |
Released Forecast Spread |
| 5,30 3,64 46% | -50,0 -46,4 -7,8% | 5,87 -8,55 169% | 1,69 6,04 -72% | -7,51 1,64 -559% | 1,80 6,23 -71% | -21,6 8,72 -348% | -36,7 4,93 -845% | 19,2 7,13 169% | 18,5 | 17,8 | 22,3 | 13,3 | 20,8 |
EPS $ |
Released Forecast Spread |
| 0,10 0,12 -19% | -0,98 -0,84 -16% | 0,11 -0,16 170% | 0,03 0,14 -79% | -0,15 0,07 -315% | 0,03 0,17 -83% | -0,42 0,22 -289% | -0,71 0,15 -589% | 0,35 0,15 139% | 0,32 | 0,30 | 0,40 | 0,31 | 0,37 | Announcement Date | 02/20/2020 | 05/06/2020 | 08/04/2020 | 10/29/2020 | 02/25/2021 | 05/05/2021 | 07/28/2021 | 11/09/2021 | 02/23/2022 | 05/04/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for NUVASIVE, INC. |
|
|
|
Past sector events for NUVASIVE, INC. |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|